Form 4 for CBLL Ceribell, Inc.
Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-15 · accession 0000950170-25-074106 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-05-19 | 2025-05-15 | CBLL | Chao Xingjuan | Pres, CEO, Dir | M - OptEx | $1.02 | +73.9K | 752.2K | +11% | +$75.1K |
| DT | 2025-05-19 | 2025-05-15 | CBLL | Chao Xingjuan | Pres, CEO, Dir | S - Sale+OE | $16.96 | -25.0K | 727.2K | -3% | -$424.0K |
| DMT | 2025-05-19 | 2025-05-15 | CBLL | Chao Xingjuan | Pres, CEO, Dir | M - OptEx | $0.00 | -73.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-15 | M | A | 48,871 | $0.39 | 776,022 | D | — | — | |
| 2 | Common | Common Stock | 2025-05-15 | S | D | 25,000 | $16.96 | 727,151 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.08 to $17.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. |
| 3 | Common | Common Stock | 2025-05-15 | M | A | 25,000 | $2.24 | 752,151 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-05-15 | M | D | 25,000 | $0.00 | 102,551 | D | $2.24 · — to 2029-06-10 | 25,000 Common Stock | (F5) The option was granted on November 10, 2015 and is fully vested and exercisable as of the transaction date. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-05-15 | M | D | 48,871 | $0.00 | 0 | D | $0.39 · — to 2025-11-10 | 48,871 Common Stock | (F6) The option was granted on July 7, 2021 and is fully vested and exercisable as of the transaction date. |